Drug recall · January 12, 2022
Gatifloxacin Ophthalmic Solution recall
Why: Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-435-01.
- Lots / codes
Lot #: H003037, exp. date May 2022; H100132, exp. date June 2022; H100847, exp. date October 2022
- Quantity
- 50,832 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- December 22, 2021 · Voluntary: Firm initiated
- Classified
- January 4, 2022
- Reported
- January 12, 2022
- Ended
- September 12, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gatifloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.